Scientists have identified a compound produced by gut bacteria that sharply improves how tumors respond to immunotherapy, offering a potential breakthrough for patients…
Cornell researchers have developed particles that can supercharge immunotherapy, offering a breakthrough approach to treating resistant cancers. The nanoparticles work in…
Rail Vision operates in large and growing markets for railway safety, collision avoidance, and autonomous train technologies supported by favorable…
ParaZero has successfully demonstrated the company’s DefendAir platform for the first time on European soil, following a distribution agreement that…
Health IT firms in the U.S. are calling for clearer, more consistent AI rules as conflicting state regulations create mounting challenges for companies operating across…
GridAI Technologies provides exposure to the convergence of artificial intelligence, energy infrastructure modernization, and large-scale electrification trends. The Grid AI…
ParaZero operates as a defense aerospace company specializing in multi-layered Counter-UAS solutions for modern battlefield and homeland security environments. The…
University of North Carolina researchers have developed a combination treatment that shows remarkable promise against glioblastoma, an aggressive brain cancer…
LIXTE is advancing a first-in-class PP2A inhibitor platform designed to enhance, rather than replace, established chemotherapy and immunotherapy regimens. The…
A gene regulator best known for its role in bone development is now emerging as a potential lever to restore…